Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The history now shows Revision: v3.6.0 and removes the prior Revision: v3.5.5 entry.
    Difference
    0.2%
    Check dated 2026-06-13T17:56:22.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the study record history, representing an updated version of the record. The previous revision v3.5.4 remains part of the history as the prior version.
    Difference
    0.1%
    Check dated 2026-06-06T14:46:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the study record history, replacing the prior v3.5.3. This reflects an updated version of the record in the history.
    Difference
    0.1%
    Check dated 2026-05-16T09:19:33.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page reflects a change in the site/system revision label, indicating an interface or platform version update without modifying the underlying clinical trial record details.
    Difference
    0.1%
    Check dated 2026-04-25T06:18:02.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Added a Study Status entry and removed an older version date in the record history.
    Difference
    0.2%
    Check dated 2026-04-03T19:24:19.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This appears to be a UI/backend update with no changes to study data or functionality.
    Difference
    0.1%
    Check dated 2026-03-20T06:38:03.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.